From: Familial cancer among consecutive uterine cancer patients in Sweden
 | Cancer site | Observed number | Proportion [%] | LL 95% | UL 95% | Proportion [%] in Sweden 1970 | Proportion [%] in Sweden 2010 | Reference outside CI |
---|---|---|---|---|---|---|---|---|
1 | Breast | 207 | 15.73 | 13.75 | 17.71 | 14.57 | 19.84 | No |
2 | Unspecified | 140 | 10.64 | 8.97 | 12.31 | 3.29 | 2.26 | CI above reference |
3 | Stomach/unspecified abdomen | 127 | 9.65 | 8.05 | 11.25 | 7.04 | 1.38 | CI above reference |
4 | Prostate | 115 | 8.74 | 7.22 | 10.26 | 7.89 | 13.21 | No |
5 | Colon | 109 | 8.28 | 6.84 | 9.8 | 7.75 | 6.81 | No |
6 | Lung and airways | 81 | 6.16 | 4.86 | 7.45 | 5.89 | 6.26 | No |
7 | Uterus | 73 | 5.55 | 4.33 | 6.84 | 3.73 | 3.05 | CI above reference |
8 | Biliary passages and liver | 49 | 3.72 | 2.74 | 4.79 | 3.27 | 1.54 | No |
9 | Cervix | 45 | 3.42 | 2.51 | 4.41 | 3.73 | 1.26 | No |
10 | Brain and nervous system | 45 | 3.42 | 2.51 | 4.41 | 3.47 | 3.01 | No |
11 | Rectum | 34 | 2.58 | 1.75 | 3.5 | 3.96 | 3.64 | CI below reference |
12 | Pancreas | 32 | 2.43 | 1.67 | 3.27 | 3.14 | 1.66 | No |
13 | Ovary/fallopian tube | 30 | 2.28 | 1.52 | 3.12 | 4.11 | 1.79 | No |
14 | Kidney | 28 | 2.13 | 1.37 | 2.96 | 3.71 | 1.86 | No |
15 | Malignant melanoma | 28 | 2.13 | 1.37 | 2.96 | 2.18 | 5.83 | No |
16 | Other skin cancer | 24 | 1.82 | 1.14 | 2.58 | 2.32 | 7.45 | No |
17 | Leukemia | 23 | 1.75 | 1.06 | 2.51 | 2.56 | 2.31 | No |
18 | Urinary tract | 20 | 1.52 | 0.91 | 2.2 | 3.64 | 3.77 | CI below reference |
19 | Larynx | 15 | 1.14 | 0.61 | 1.75 | 0.51 | 0.29 | CI above reference |
20 | Hodgkin’s disease | 12 | 0.91 | 0.46 | 1.44 | 0.94 | 0.41 | No |
21 | Multiple myeloma | 12 | 0.91 | 0.46 | 1.44 | 1.25 | 1.09 | No |
22 | Bone | 11 | 0.84 | 0.38 | 1.37 | 0.25 | 0.14 | CI above reference |
23 | Non-Hodgkin lymphoma | 11 | 0.84 | 0.38 | 1.37 | 2.27 | 2.99 | CI below reference |
24 | Thyroid | 10 | 0.76 | 0.3 | 1.29 | 1.02 | 1.11 | No |
25 | Esophagus | 9 | 0.68 | 0.3 | 1.14 | 0.79 | 0.6 | No |
26 | Connective tissue | 9 | 0.68 | 0.3 | 1.14 | 0.7 | 0.53 | No |
27 | Lip/tongue/mouth | 6 | 0.46 | 0.15 | 0.84 | 1.18 | 0.98 | CI below reference |
28 | Vulva/vagina | 3 | 0.23 | 0 | 0.53 | 0.56 | 0.43 | No |
29 | Testis | 3 | 0.23 | 0 | 0.53 | 0.4 | 0.75 | No |
30 | Endocrine glands (excl thyroid) | 2 | 0.15 | 0 | 0.38 | 1.45 | 1.32 | CI below reference |
31 | Polycytemia vera | 2 | 0.15 | 0 | 0.38 | 0.39 | 0.24 | No |
32 | Penis/scrotum | 1 | 0.08 | 0 | 0.23 | 0.18 | 0.11 | No |
33 | Salivary gland | 0 | 0 | 0 | 0 | 0.28 | 0.21 | CI below reference |
34 | Pharynx | 0 | 0 | 0 | 0 | 0.44 | 0.6 | CI below reference |
35 | Small intestine, including duodenum | 0 | 0 | 0 | 0 | 0.42 | 0.48 | CI below reference |
36 | Peritoneum | 0 | 0 | 0 | 0 | 0.02 | 0.14 | CI below reference |
37 | Nose, nasal cavities, middle ear and accessory sinuses | 0 | 0 | 0 | 0 | 0.28 | 0.12 | CI below reference |
38 | Mediastinum | 0 | 0 | 0 | 0 | 0.02 | 0.01 | CI below reference |
39 | Eye | 0 | 0 | 0 | 0 | 0.32 | 0.25 | CI below reference |
40 | Myelofibrosis | 0 | 0 | 0 | 0 | 0.03 | 0.27 | CI below reference |